EW

Insider trade Sale by Dahl Andrew M. (SVP, Corporate Controller)

3d ago

Insider trade Sale by BOBO DONALD E JR (CVP,Strategy/Corp Development)

5d ago

Insider trade Sale by Chopra Daveen (CVP, TMTT & Surgical)

10d ago

News FTC Sounds Alarm On Edwards' Attempt To Corner Heart Device Market

14d ago

News Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens

14d ago

News Jim Cramer: Healthpeak Properties Is A 'Reasonable' REIT, Recommends Buying This Health Care Stock

14d ago

News Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry

14d ago

News US Hospitals Face Critical IV Fluid Shortage After Baxter Facility Shuts Down Due To Hurricane Helene

14d ago

News The Analyst Landscape: 13 Takes On Edwards Lifesciences

14d ago

Insider trade Sale by BOBO DONALD E JR (CVP,Strategy/Corp Development)

14d ago

News BD (BDX) Inks Buyout Deal to Expand Smart Connected Care Suite

14d ago

News Stock index futures fall as U.S.-China talks avoid chips discussion

18d ago

Insider trade Sale by Bernard J Zovighian (CEO)

20d ago

Insider trade Sale by Wayne Markowitz (CVP, JAPAC)

21d ago

Insider trade Sale by Daniel J. Lippis (CVP, TAVR)

28d ago

Short volume Short volume 62% of volume (4.5σ)

33d ago

News Edwards forecasts 9%-11% 2026 sales growth and $2.95-$3.05 adjusted EPS as TAVR guide rises to 7%-9%

39d ago

News Edwards Lifesciences Non-GAAP EPS of $0.78 beats by $0.05, revenue of $1.65B beats by $50M

39d ago

SEC filing EW Reports $1.65B Revenue, $0.66 EPS, Raises FY26 Sales Guidance to 9-11% YoY

39d ago

News Notable healthcare headlines for the week: Organon, Eli Lilly, and Gilead in focus

51d ago

Insider trade Sale by Scott B. Ullem (CVP, Chief Financial Officer)

53d ago

Insider trade Sale by Daniel J. Lippis (CVP, TAVR)

56d ago

Insider trade Sale by Daniel J. Lippis (CVP, TAVR)

82d ago

Insider trade Sale by Scott B. Ullem (CVP, Chief Financial Officer)

82d ago

Insider trade Sale by Donald E Bobo JR (CVP,Strategy/Corp Development)

91d ago